What is Immix Biopharma, Inc.'s net investment in lease?

Immix Biopharma, Inc. (IMMX) reported net investment in lease of $927.73K in Q1 2026.

How has Immix Biopharma, Inc.'s net investment in lease changed year-over-year?

Immix Biopharma, Inc.'s net investment in lease decreased by 21.2% year-over-year, from $1.18M to $927.73K.

Immix Biopharma, Inc. IMMX Net Investment in Lease

Net Investment in Lease at other companies

Allogene TherapeuticsALLO

——

RegenxbioRGNX

——

Kyverna Therapeutics, Inc.KYTX

——

XencorXNCR

——

ImmunomeIMNM

——

PrecigenPGEN

——

Other financials

Income statement

See full

Operating income-$10.8M-131%

Net income-$10.1M-122%

EPS (diluted)-$0.18-20.0%

Balance sheet

See full

Cash & equivalents$79.3M+398%

Total debt$1.0M-2.0%

Total equity$84.4M+779%

Total assets$95.8M+382%

Cash flow

See full

Operating cash flow-$9.8M-483%

CapEx$32.5K-52.0%

Free cash flow-$9.9M-462%

Valuation

See full

Market cap$691.97M+1,008%

Enterprise value$613.75M+1,190%

Returns & leverage

See full

Return on equity-74.4%-18.6pp

Debt / equity0×-0.1×

Current ratio8.8×+7.0×

Where this comes from

Reported directly by Immix Biopharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immix Biopharma, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immix Biopharma, Inc.'s net investment in lease?: Immix Biopharma, Inc. (IMMX) reported net investment in lease of $927.73K in Q1 2026.
How has Immix Biopharma, Inc.'s net investment in lease changed year-over-year?: Immix Biopharma, Inc.'s net investment in lease decreased by 21.2% year-over-year, from $1.18M to $927.73K.